These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1298182)

  • 1. [Hirudin and hirudin fragments].
    Deschamps A; Samama M
    Ann Cardiol Angeiol (Paris); 1992 Oct; 41(8):A49-53. PubMed ID: 1298182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
    Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
    Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic and haemorrhagic effects of the naturally occurring thrombin inhibitor hirudin.
    Kaiser B; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):41-6. PubMed ID: 2459030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hirudin as alternative anticoagulant--a historical review.
    Markwardt F
    Semin Thromb Hemost; 2002 Oct; 28(5):405-14. PubMed ID: 12420235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of selective thrombin inhibitors.
    Markwardt F
    Nouv Rev Fr Hematol (1978); 1988; 30(3):161-5. PubMed ID: 3047669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leeches to hirulogs and other thrombin-directed antithrombotics.
    Fenton JW
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1121-9. PubMed ID: 1400076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comeback of hirudin as an antithrombotic agent.
    Markwardt F
    Semin Thromb Hemost; 1991 Apr; 17(2):79-82. PubMed ID: 1771415
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of heparin-resistant microarterial thrombosis by recombinant hirudin: a specific thrombin inhibitor.
    Arnljots B; Bergqvist D
    Plast Reconstr Surg; 1995 Apr; 95(5):894-900. PubMed ID: 7708874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The direct thrombin inhibitor hirudin.
    Greinacher A; Warkentin TE
    Thromb Haemost; 2008 May; 99(5):819-29. PubMed ID: 18449411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology of recombinant hirudin (CGP 39393): a new prospect in the treatment of thrombosis.
    Talbot M
    Semin Thromb Hemost; 1989 Jul; 15(3):293-301. PubMed ID: 2688102
    [No Abstract]   [Full Text] [Related]  

  • 11. Hirudin: clinical potential of a thrombin inhibitor.
    Johnson PH
    Annu Rev Med; 1994; 45():165-77. PubMed ID: 8198374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hirudin in the treatment of arterial and venous thrombotic diseases: a new perspective.
    Büller HR
    Z Kardiol; 1993; 82 Suppl 2():81-2. PubMed ID: 8328213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of hirudin as an antithrombotic agent.
    Markwardt F
    Semin Thromb Hemost; 1989 Jul; 15(3):269-82. PubMed ID: 2688099
    [No Abstract]   [Full Text] [Related]  

  • 14. Production and evaluation of recombinant hirudin.
    Courtney M; Loison G; Lemoine Y; Riehl-Bellon N; Degryse E; Brown SW; Cazenave JP; Defreyn G; Delebassee D; Bernat A
    Semin Thromb Hemost; 1989 Jul; 15(3):288-92. PubMed ID: 2688101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the dosage of recombinant hirudin to inhibit arterial thrombosis in baboons.
    Kotzé HF; Lamprecht S; Van Wyk V; Roodt JP; Badenhorst PN
    J Pharm Sci; 2000 May; 89(5):579-85. PubMed ID: 10756323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin.
    Agnelli G; Renga C; Weitz JI; Nenci GG; Hirsh J
    Blood; 1992 Aug; 80(4):960-5. PubMed ID: 1498336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of recombinant hirudin as a therapeutic anticoagulant and antithrombotic agent: some objective considerations.
    Walenga JM; Pifarre R; Hoppensteadt DA; Fareed J
    Semin Thromb Hemost; 1989 Jul; 15(3):316-33. PubMed ID: 2688104
    [No Abstract]   [Full Text] [Related]  

  • 18. Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis Group.
    Verstraete M; Nurmohamed M; Kienast J; Siebeck M; Silling-Engelhardt G; Büller H; Hoet B; Bichler J; Close P
    J Am Coll Cardiol; 1993 Oct; 22(4):1080-8. PubMed ID: 8409044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies on various assays for the laboratory evaluation of r-hirudin.
    Walenga JM; Hoppensteadt D; Koza M; Pifarre R; Fareed J
    Semin Thromb Hemost; 1991 Apr; 17(2):103-12. PubMed ID: 1771408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hirudin: the relative failure of a very promising molecule].
    Aiach M
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1485-90. PubMed ID: 9092407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.